Table 5.
Univariate and Multivariate analysis of the predictive factors of EAOC in the current cohort.
| Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|
| Risk Ratio (95% CI) | p-Value | Risk Ratio (95% CI) | p-Value | ||
| Age | ≤47.50 | 1.00 (referent) | 1.00 (referent) | ||
| (years) | >47.50 | 21.21 (7.93–56.71) | <0.001 | 14.35 (2.89–71.04) | 0.001 |
| Cyst size | ≤85.74 | 1.00 (referent) | 1.00 (referent) | ||
| (mm) | >85.74 | 19.62 (7.97–48.31) | <0.001 | 14.40 (3.26–63.51) | <0.001 |
| CEA | ≤0.95 | 1.00 (referent) | |||
| (ng/mL) | >0.95 | 4.34 (1.84–10.18) | 0.001 | ||
| Lymphocytes | >22.50 | 1.00 (referent) | |||
| (%) | ≤22.50 | 4.19 (1.82–9.61) | 0.001 | ||
| Lymphocytes | >16.05 | 1.00 (referent) | |||
| (×102/µL) | ≤16.05 | 4.48 (1.77–11.36) | 0.002 | ||
| Monocytes | ≤7.65 | 1.00 (referent) | |||
| (%) | >7.65 | 3.69 (1.47–9.24) | 0.005 | ||
| Platelet | ≤29.25 | 1.00 (referent) | |||
| (×104/µL) | >29.25 | 2.88 (1.36–6.09) | 0.005 | ||
| CRP | ≤0.14 | 1.00 (referent) | |||
| (mg/dL) | >0.14 | 2.83 (1.33–6.03) | 0.007 | ||
| Albumin | >4.25 | 1.00 (referent) | |||
| (g/dL) | ≤4.25 | 2.89 (1.28–6.53) | 0.010 | ||
| D-dimer | ≤0.75 | 1.00 (referent) | |||
| (µg/mL) | >0.75 | 3.46 (1.52–7.85) | 0.003 | ||
| APTT | >27.75 | 1.00 (referent) | |||
| (second) | ≤27.75 | 2.54 (1.20–5.37) | 0.014 | ||
| R2 | >13.76 | 1.00 (referent) | 1.00 (referent) | ||
| (s−1) | ≤13.76 | 24.85 (9.26–66.69) | <0.001 | 10.23 (2.60–40.20) | 0.001 |
CEA carcinoembryonic antigen, CRP C-reactive protein, APTT activated partial thromboplastin time. The R2 value was calculated as a fraction.